Drugs / 18F-Al-NOTA-PRGD2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02441972 | Jan 2012 → Dec 2020 | breast carcinoma, bronchogenic carcinoma, head and neck cancer, lymphoma +1 | Wuxi No. 4 People's Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-Al-NOTA-PRGD2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02441972 ↗ |
| Modality | Diagnostic / imaging agent | “18F-Al-NOTA-PRGD2(PET imaging agent)” NCT02441972 ↗ |
| Route | Intravenous | “18F-Al-NOTA-PRGD2(PET imaging agent) given by vein before PET scans.” NCT02441972 ↗ |